Cargando…

First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?

SIMPLE SUMMARY: First-line treatment options for metastatic clear cell renal cell carcinoma have significantly increased. The current recommended therapeutic strategy is based on a combination, but monotherapy remains an alternative. However, the choice of the type of combination, i.e., dual immunot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vano, Yann-Alexandre, Ladoire, Sylvain, Elaidi, Réza, Dermeche, Slimane, Eymard, Jean-Christophe, Falkowski, Sabrina, Gross-Goupil, Marine, Malouf, Gabriel, Narciso, Bérangère, Sajous, Christophe, Tartas, Sophie, Voog, Eric, Ravaud, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583335/ https://www.ncbi.nlm.nih.gov/pubmed/34771710 http://dx.doi.org/10.3390/cancers13215548

Ejemplares similares

Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
por: Elaidi, Reza, et al.
Publicado: (2020)

Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade
por: Larroquette, Mathieu, et al.
Publicado: (2022)

Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?
por: Gross-Goupil, Marine, et al.
Publicado: (2012)

An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
por: Iaxx, Romain, et al.
Publicado: (2022)

Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106)
por: Mebroukine, Samy, et al.
Publicado: (2022)

Correction to: Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort: THE for locally advanced GEJC
por: Meillat, Hélène, et al.
Publicado: (2022)

Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort: THE for locally advanced GEJC
por: Meillat, Hélène, et al.
Publicado: (2022)

Hepatocellular Carcinoma in a Noncirrhotic Liver after Long-Term Use of Danazol for Hereditary Angioedema
por: Rahal, Soraya, et al.
Publicado: (2014)

Optimal management of renal cell carcinoma in the elderly: a review
por: Quivy, Amandine, et al.
Publicado: (2013)

Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
por: Granet-Vaissiere, Estelle, et al.
Publicado: (2023)

Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges
por: Fournier, Laure, et al.
Publicado: (2017)

Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma
por: Gross-Goupil, Marine, et al.
Publicado: (2013)

Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients
por: Vano, Yann-Alexandre, et al.
Publicado: (2018)

Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Maillet, Denis, et al.
Publicado: (2021)

Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up
por: Guerin, Mathilde, et al.
Publicado: (2013)

Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital
por: Heraudet, Luc, et al.
Publicado: (2020)

Selecting the most appropriate treatment for each patient
por: Beutler, Larry E., et al.
Publicado: (2016)

Choosing the most appropriate cut-point for continuous variables
por: TUSTUMI, FRANCISCO
Publicado: (2022)

RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
por: Deandreis, Désirée, et al.
Publicado: (2021)

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response
por: Teyssonneau, Diego, et al.
Publicado: (2017)

Which is the Most Appropriate Disconnection Surgery for Refractory Epilepsy in Childhood?
por: Kishima, Haruhiko, et al.
Publicado: (2013)

Test of association: which one is the most appropriate for my study?
por: Gonzalez-Chica, David Alejandro, et al.
Publicado: (2015)

A case of primary clear cell hepatocellular carcinoma comprised mostly of clear cells
por: Kokubo, Reiji, et al.
Publicado: (2019)

Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
por: Simonaggio, Audrey, et al.
Publicado: (2021)

Tools to identify the men with prostate cancer most appropriate for active surveillance?
por: Getzenberg, Robert H
Publicado: (2014)

Describing numerical variables: which are the most appropriate parameters to describe the data?
por: Duquia, Rodrigo Pereira, et al.
Publicado: (2017)

Selecting the most appropriate time points to profile in high-throughput studies
por: Kleyman, Michael, et al.
Publicado: (2017)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

An authoritative algorithm most appropriate for the prediction of pulmonary embolism in patients with AECOPD
por: Xiong, Wei, et al.
Publicado: (2020)

Assessing the Effect of Mycotoxin Combinations: Which Mathematical Model Is (the Most) Appropriate?
por: Kifer, Domagoj, et al.
Publicado: (2020)

Management of Immune Checkpoint Inhibitor Toxicities
por: Durrechou, Quentin, et al.
Publicado: (2020)

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma
por: Sigrand, Julie, et al.
Publicado: (2016)

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas
por: Lu, Xiaofan, et al.
Publicado: (2023)

Chart for Thermoelectric Systems Operation Based on a Ternary Diagram for Bithermal Systems
por: Ramousse, Julien, et al.
Publicado: (2018)

Adapted or Adaptable: How to Manage Entropy Production?
por: Goupil, Christophe, et al.
Publicado: (2019)

The most important tasks for peer reviewers evaluating a randomized controlled trial are not congruent with the tasks most often requested by journal editors
por: Chauvin, Anthony, et al.
Publicado: (2015)

Resolving the Phylogenetic Position of Coelacanth: The Closest Relative Is Not Always the Most Appropriate Outgroup
por: Takezaki, Naoko, et al.
Publicado: (2016)

How to choose the most appropriate technique for the single-stage treatment of cholecysto-choledocolithiasis?
por: Bove, Aldo, et al.
Publicado: (2019)

The Choice of the Most Appropriate Suture Threads for Pancreatic Anastomoses on the Basis of Their Mechanical Characteristics
por: Pagnanelli, Michele, et al.
Publicado: (2023)

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience
por: Gonnet, Alexis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mt99ssa4ei73ju1khldp695e05